TCTR20190515001招募中4 期
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatment
Center of Excellence for Pediatric Infectious Diseases and Vaccines0 个研究点目标入组 20 人开始时间: 2019年5月15日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 Months 至 15 Years（—）
- 性别
- All
入选标准
- •1) age 3 months to 15 years
- •2) having an indication to used levofloxacin for tuberculosis treatment (MDR-TB, Hr-TB, toxicity from the first line drug)
- •3) weight 6-40 kilogram
- •4) primary caregiver give consent and children aged more than 7 years give assent.
排除标准
- •1) History allergic to levofloxacin
- •2) Levofloxacin resistant tuberculosis
- •3) Medical history of QT prolong
- •4) Pregnancy
研究者
相似试验
进行中（未招募）
1 期
Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia - Lévo-PharmMedDRA version: 14.0 Level: LLT Classification code 10032502 Term: Other specified alveolar and parietoalveolar pneumopathies System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorderscommunity-acquired pneumoniaEUCTR2011-002177-34-FRCHU de Toulouse65
已完成
不适用
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200
已完成
不适用
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adultsJPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300
已完成
不适用
Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in AdultsJPRN-UMIN000011837Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan60
进行中（未招募）
不适用
Pharmacokinetics and safety of moxifloxacin; a dose escalation in patients with tuberculosis - Pharmacokinetics and safety of moxifloxaciMedDRA version: 12.1Level: LLTClassification code 10044755Term: TuberculosisTuberculosisEUCTR2010-023491-25-NLniversity Medical Center Groningen